PKM and pancreatic ductal adenocarcinoma: Calabretta et al. found that knockdown of PTBP1 in drug resistant-pancreatic ductal adenocarcinoma cells (DR-PDAC) reduced its recruitment to PKM pre-mRNA, increased the splicing of PKM1 variant, reduced PKM2 isoform and abolished drug resistance [48].